Erlotinib vs Montelukast

Erlotinib vs Montelukast: Overview

This comparison examines the pharmacological differences between Erlotinib and Montelukast.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Montelukast — C35H36ClNO3S.

Molecular Weight: Erlotinib — 393.4380 g/mol; Montelukast — 586.1800 g/mol.

Type: Erlotinib — Small molecule; Montelukast — Small molecule.